Phase I study of a B-HDM regimen for elderly multiple myeloma patients
Latest Information Update: 29 Apr 2019
At a glance
- Drugs Bortezomib (Primary) ; Melphalan (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- Acronyms B-HDM regimen
- 25 Apr 2019 Status changed from recruiting to completed.
- 23 Jan 2013 New trial record